NEW YORK, Dec. 11-The bioinformatics company TimeLogic said yesterday that it had added Paragon Bioinformatics' Darrell Ricke to its scientific advisory board.
At Los Alamos National Laboratory, Ricke developed gene discovery software that helped identify the gene for Familial Mediterranean Fever.
He is currently bioinformatics director at Paragon.
TimeLogic is based in Crystal Bay, Nev.
Mark Emkjer has been appointed president of Accelrys, the software subsidiary of Pharmacopeia, the pharmaceutical company said on Dec. 9.
Emkjer was previously president and chief operating officer of Sunquest Information Systems, which provides information systems to hospitals, labs and clinics.
Klaus Schollmeier was named chief executive officer of Graffinity Pharmaceuticals by its supervisory board on Dec. 9.
Schollmeier was previously managing director of the healthcare/biotechnology group at ING-BHF Bank for ING Group Europe. Before that, he spent 16 years in pharmaceutical development at BASF.
Graffinity's core technology uses chemical microarrays to observe the interactions between compounds and protein drug targets. The company has partnerships with pharmaceutical companies and also plans to develop its own drug candidates.
Graffinity Pharmaceuticals is based in Heidelberg.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.